In last trading session, Lucid Diagnostics Inc (NASDAQ:LUCD) saw 0.38 million shares changing hands with its beta currently measuring 1.49. Company’s recent per share price level of $0.96 trading at $0.04 or 3.68% at ring of the bell on the day assigns it a market valuation of $56.85M. That closing price of LUCD’s stock is at a discount of -56.25% from its 52-week high price of $1.50 and is indicating a premium of 34.37% from its 52-week low price of $0.63. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.19 million shares which gives us an average trading volume of 440.41K if we extend that period to 3-months.
For Lucid Diagnostics Inc (LUCD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.
Lucid Diagnostics Inc (NASDAQ:LUCD) trade information
Upright in the green during last session for gaining 3.68%, in the last five days LUCD remained trading in the green while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $0.96 price level, adding 0.09% to its value on the day. Lucid Diagnostics Inc’s shares saw a change of 17.00% in year-to-date performance and have moved 6.55% in past 5-day. Lucid Diagnostics Inc (NASDAQ:LUCD) showed a performance of 19.72% in past 30-days. Number of shares sold short was 0.54 million shares which calculate 1.65 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 2.5 to the stock, which implies a rise of 61.6% to its current value. Analysts have been projecting 2.5 as a low price target for the stock while placing it at a high target of 2.5. It follows that stock’s current price would drop -160.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -160.42% for stock’s current value.
Lucid Diagnostics Inc (LUCD) estimates and forecasts
Statistics highlight that Lucid Diagnostics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 20.11% of value to its shares in past 6 months, showing an annual growth rate of 18.48% while that of industry is 14.40. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 88.04% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.42M for the same. And 5 analysts are in estimates of company making revenue of 1.61M in the next quarter. Company posted 1.04M and 1M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -110.66% during past 5 years.
Lucid Diagnostics Inc (NASDAQ:LUCD)’s Major holders
Insiders are in possession of 60.83% of company’s total shares while institution are holding 5.07 percent of that, with stock having share float percentage of 12.94%. Investors also watch the number of corporate investors in a company very closely, which is 5.07% institutions for Lucid Diagnostics Inc that are currently holding shares of the company. LUMINUS MANAGEMENT LLC is the top institutional holder at LUCD for having 0.73 million shares of worth $0.6 million. And as of 2024-06-30, it was holding 1.6124 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.56 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.2461 of outstanding shares, having a total worth of $0.46 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 366.92 shares of worth $0.35 million or 0.62% of the total outstanding shares. The later fund manager was in possession of 193.99 shares on Sep 30, 2024 , making its stake of worth around $0.19 million in the company or a holder of 0.33% of company’s stock.
